Cargando…
MAGE-A1 in lung adenocarcinoma as a promising target of chimeric antigen receptor T cells
BACKGROUND: Cancer/testis antigens (CTAs) are a special type of tumor antigen and are believed to act as potential targets for cancer immunotherapy. METHODS: In this study, we first screened a rational CTA MAGE-A1 for lung adenocarcinoma (LUAD) and explored the detailed characteristics of MAGE-A1 in...
Autores principales: | Mao, Yuan, Fan, Weifei, Hu, Hao, Zhang, Louqian, Michel, Jerod, Wu, Yaqin, Wang, Jun, Jia, Lizhou, Tang, Xiaojun, Xu, Li, Chen, Yan, Zhu, Jin, Feng, Zhenqing, Xu, Lin, Yin, Rong, Tang, Qi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805483/ https://www.ncbi.nlm.nih.gov/pubmed/31640756 http://dx.doi.org/10.1186/s13045-019-0793-7 |
Ejemplares similares
-
CD137 Co-Stimulation Improves The Antitumor Effect Of LMP1-Specific Chimeric Antigen Receptor T Cells In Vitro And In Vivo
por: Tang, Xiaojun, et al.
Publicado: (2019) -
c-Met-targeted chimeric antigen receptor T cells inhibit hepatocellular carcinoma cells in vitro and in vivo
por: Huang, Xiaochen, et al.
Publicado: (2022) -
Rab27b Is a Potential Indicator for Lymph Node Metastasis and Unfavorable Prognosis in Lung Adenocarcinoma
por: Zhang, Louqian, et al.
Publicado: (2018) -
FLOT1 promotes tumor development, induces epithelial–mesenchymal transition, and modulates the cell cycle by regulating the Erk/Akt signaling pathway in lung adenocarcinoma
por: Zhang, Louqian, et al.
Publicado: (2019) -
T cells expressing a LMP1-specific chimeric antigen receptor mediate antitumor effects against LMP1-positive nasopharyngeal carcinoma cells in vitro and in vivo
por: Tang, Xiaojun, et al.
Publicado: (2014)